BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 17415114)

  • 1. Immunohistochemical expression of p16(INK4A) in normal uterine cervix, nonneoplastic epithelial lesions, and low-grade squamous intraepithelial lesions.
    Focchi GR; Silva ID; Nogueira-de-Souza NC; Dobo C; Oshima CT; Stavale JN
    J Low Genit Tract Dis; 2007 Apr; 11(2):98-104. PubMed ID: 17415114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of p16INK4a immunoexpression and human papillomavirus (HPV) detected by in-situ hybridization in cervical squamous neoplasia.
    Cheah PL; Koh CC; Nazarina AR; Teoh KH; Looi LM
    Malays J Pathol; 2016 Apr; 38(1):33-8. PubMed ID: 27126662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical value of p16
    Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
    [No Abstract]   [Full Text] [Related]  

  • 4. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
    Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
    Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the diagnostic and prognostic significance of p16(INK4a) /p21(WAF1/Cip1) immunostaining in squamous intraepithelial lesions of the uterine cervix using liquid-based cytology specimens.
    Ishida K; Araki A; Kobayashi M; Taniyama K; Nabika T; Nagasaki M
    Diagn Cytopathol; 2014 Feb; 42(2):125-33. PubMed ID: 23754829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
    Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
    Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunochemical assessment of p16 and HPV L1 capsid protein in cervical squamous intraepithelial lesions.
    Balan R; Giuşcă S; Căruntu ID; Gheorghiţă V; Neacşu D; Amălinei C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1118-24. PubMed ID: 21495457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
    Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
    Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
    Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
    Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application.
    Zhou WQ; Sheng QY; Sheng YH; Hou WJ; Xu GX; Wu YM; Lu H
    Eur J Gynaecol Oncol; 2015; 36(1):62-8. PubMed ID: 25872337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIRT1 overexpression in cervical squamous intraepithelial lesions and invasive squamous cell carcinoma.
    Velez-Perez A; Wang XI; Li M; Zhang S
    Hum Pathol; 2017 Jan; 59():102-107. PubMed ID: 27720890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus detection and p16INK4a expression in cervical lesions: a comparative study.
    Genovés J; Alameda F; Mancebo G; Solé JM; Bellosillo B; Lloveras B; Agramunt S; Baró MT; Muset M; Casado B; Serrano L; Miralpeix E; Carreras R
    Hum Pathol; 2014 Apr; 45(4):826-33. PubMed ID: 24656093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver reproducibility in determining p16 overexpression in cervical lesions : use of a combined scoring method.
    Vinyuvat S; Karalak A; Suthipintawong C; Tungsinmunkong K; Kleebkaow P; Trivijitsilp P; Siriaunkgul S; Triratanachat S; Khunamornpong S; Chuangsuwanich T; Settakorn J
    Asian Pac J Cancer Prev; 2008; 9(4):653-7. PubMed ID: 19256755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The evaluation of p16INK4a immunoexpression/immunostaining and human papillomavirus DNA test in cervical liquid-based cytological samples.
    Nasioutziki M; Daniilidis A; Dinas K; Kyrgiou M; Valasoulis G; Loufopoulos PD; Paraskevaidis E; Loufopoulos A; Karakitsos P
    Int J Gynecol Cancer; 2011 Jan; 21(1):79-85. PubMed ID: 21330832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16 INK4A is a strong biomarker for cervical intraepithelial neoplasia and invasive cervical carcinoma: a reappraisal.
    Haidopoulos D; Partsinevelos GA; Vlachos GD; Rodolakis A; Markaki S; Voulgaris Z; Diakomanolis E; Antsaklis A
    Reprod Sci; 2009 Jul; 16(7):685-93. PubMed ID: 19372590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p16 ink4a and HPV L1 immunohistochemistry is helpful for estimating the behavior of low-grade dysplastic lesions of the cervix uteri.
    Negri G; Bellisano G; Zannoni GF; Rivasi F; Kasal A; Vittadello F; Antoniazzi S; Faa G; Ambu R; Egarter-Vigl E
    Am J Surg Pathol; 2008 Nov; 32(11):1715-20. PubMed ID: 18769337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of p16 and galectin-3 in cervical intraepithelial neoplasia (CIN) and squamous cell carcinoma (SCC) uterine cervix.
    Kumar R; Mandal S; Arora P; Mala YM; Khurana N
    J Obstet Gynaecol; 2021 Jul; 41(5):785-790. PubMed ID: 33073644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P16 immunostaining and HPV testing in histological specimens from the uterine cervix.
    Capobianco G; Marras V; Wenger JM; Santeufemia DA; Ambrosini G; Lutzoni R; Dessole M; Cherchi PL
    Eur J Gynaecol Oncol; 2013; 34(3):227-30. PubMed ID: 23967551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of p16INK4A and Hybrid Capture 2 human papillomavirus testing as adjunctive tests in liquid-based gynecologic SurePath preparations.
    Nassar A; O'Reilly K; Cohen C; Siddiqui MT
    Diagn Cytopathol; 2008 Mar; 36(3):142-8. PubMed ID: 18232003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.